Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Activation of prostaglandin E receptor 4 triggers secretion of gut hormone peptides GLP-1, GLP-2, and PYY.

Coskun T, O'Farrell LS, Syed SK, Briere DA, Beavers LS, Dubois SL, Michael MD, Franciskovich JB, Barrett DG, Efanov AM.

Endocrinology. 2013 Jan;154(1):45-53. doi: 10.1210/en.2012-1446. Epub 2012 Nov 9.

PMID:
23142807
2.

Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.

Wang JH, Inoue T, Higashiyama M, Guth PH, Engel E, Kaunitz JD, Akiba Y.

J Pharmacol Exp Ther. 2011 Nov;339(2):464-73. doi: 10.1124/jpet.111.184788. Epub 2011 Aug 16.

3.
4.
5.

Role of enteroendocrine L-cells in arginine vasopressin-mediated inhibition of colonic anion secretion.

Pais R, Rievaj J, Meek C, De Costa G, Jayamaha S, Alexander RT, Reimann F, Gribble F.

J Physiol. 2016 Sep 1;594(17):4865-78. doi: 10.1113/JP272053. Epub 2016 Apr 28.

6.

An analysis of cosecretion and coexpression of gut hormones from male rat proximal and distal small intestine.

Svendsen B, Pedersen J, Albrechtsen NJ, Hartmann B, Toräng S, Rehfeld JF, Poulsen SS, Holst JJ.

Endocrinology. 2015 Mar;156(3):847-57. doi: 10.1210/en.2014-1710. Epub 2014 Dec 23.

PMID:
25535831
7.

Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypeptide from intestinal K cells in rodents.

Moss CE, Marsh WJ, Parker HE, Ogunnowo-Bada E, Riches CH, Habib AM, Evans ML, Gribble FM, Reimann F.

Diabetologia. 2012 Nov;55(11):3094-103. doi: 10.1007/s00125-012-2663-5. Epub 2012 Aug 8.

8.
9.

A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin.

Egerod KL, Engelstoft MS, Grunddal KV, Nøhr MK, Secher A, Sakata I, Pedersen J, Windeløv JA, Füchtbauer EM, Olsen J, Sundler F, Christensen JP, Wierup N, Olsen JV, Holst JJ, Zigman JM, Poulsen SS, Schwartz TW.

Endocrinology. 2012 Dec;153(12):5782-95. doi: 10.1210/en.2012-1595. Epub 2012 Oct 12.

PMID:
23064014
10.

Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.

Heruc GA, Horowitz M, Deacon CF, Feinle-Bisset C, Rayner CK, Luscombe-Marsh N, Little TJ.

Am J Physiol Endocrinol Metab. 2014 Nov 1;307(9):E830-7. doi: 10.1152/ajpendo.00370.2014. Epub 2014 Sep 16.

11.

Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents.

Zhou J, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, Shen L, Danna SC, Tripathy S, Hegsted M, Keenan MJ.

Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1160-6. doi: 10.1152/ajpendo.90637.2008. Epub 2008 Sep 16.

12.

Receptors and effects of gut hormones in three osteoblastic cell lines.

Pacheco-Pantoja EL, Ranganath LR, Gallagher JA, Wilson PJ, Fraser WD.

BMC Physiol. 2011 Jul 29;11:12. doi: 10.1186/1472-6793-11-12.

13.

Role of MGAT2 and DGAT1 in the release of gut peptides after triglyceride ingestion.

Okawa M, Fujii K, Ohbuchi K, Okumoto M, Aragane K, Sato H, Tamai Y, Seo T, Itoh Y, Yoshimoto R.

Biochem Biophys Res Commun. 2009 Dec 18;390(3):377-81. doi: 10.1016/j.bbrc.2009.08.167. Epub 2009 Sep 2.

PMID:
19732742
15.

RANTES (CCL5) reduces glucose-dependent secretion of glucagon-like peptides 1 and 2 and impairs glucose-induced insulin secretion in mice.

Pais R, Zietek T, Hauner H, Daniel H, Skurk T.

Am J Physiol Gastrointest Liver Physiol. 2014 Aug 1;307(3):G330-7. doi: 10.1152/ajpgi.00329.2013. Epub 2014 May 29.

16.

Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.

Ullmer C, Alvarez Sanchez R, Sprecher U, Raab S, Mattei P, Dehmlow H, Sewing S, Iglesias A, Beauchamp J, Conde-Knape K.

Br J Pharmacol. 2013 Jun;169(3):671-84. doi: 10.1111/bph.12158.

17.

Activation of prostaglandin E2-EP4 signaling reduces chemokine production in adipose tissue.

Tang EH, Cai Y, Wong CK, Rocha VZ, Sukhova GK, Shimizu K, Xuan G, Vanhoutte PM, Libby P, Xu A.

J Lipid Res. 2015 Feb;56(2):358-68. doi: 10.1194/jlr.M054817. Epub 2014 Dec 15.

18.

Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells.

Habib AM, Richards P, Rogers GJ, Reimann F, Gribble FM.

Diabetologia. 2013 Jun;56(6):1413-6. doi: 10.1007/s00125-013-2887-z. Epub 2013 Mar 22.

19.

Stimulatory effect of beta-adrenergic agonists on ileal L cell secretion and modulation by alpha-adrenergic activation.

Claustre J, Brechet S, Plaisancie P, Chayvialle JA, Cuber JC.

J Endocrinol. 1999 Aug;162(2):271-8.

20.

Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.

Kay LJ, Gilbert M, Pullen N, Skerratt S, Farrington J, Seward EP, Peachell PT.

Clin Exp Allergy. 2013 Jul;43(7):741-51. doi: 10.1111/cea.12142.

PMID:
23786281

Supplemental Content

Support Center